Duquesne Family Office’s Gilead Sciences GILD Stock Holding History

Duquesne Family Office’s Portfolio GILD Stock Details GILD Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2019 Q1	–	Sell	-1,023,345	Closed	-$64M	–	66
2018 Q4	$64M	Sell	1,023,345 -441,555	-30%	-$30.9M	3.71%	10
2018 Q3	$113M	Buy	1,464,900 +259,600	+22%	+$19.6M	5.38%	6
2018 Q2	$85.4M	Buy	+1,205,300	New	+$85.1M	4.12%	7
2014 Q4	–	Sell	-217,500	Closed	-$23.2M	–	40
2014 Q3	$23.2M	Buy	+217,500	New	+$21.3M	2.84%	10
2014 Q1	–	Sell	-610,700	Closed	-$45.9M	–	31
2013 Q4	$45.9M	Hold	610,700	–	–	3.06%	9
2013 Q3	$38.4M	Hold	610,700	–	–	4.54%	7
2013 Q2	$31.3M	Buy	+610,700	New	+$31.8M	4.65%	8

Other funds holding GILD

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Duquesne Family Office's GILD Position: Q1 2019 in Review

Duquesne Family Office sold out of Gilead Sciences (GILD) in Q1 2019, closing a stake of 1,023,345 shares — an estimated $64M sold.

Duquesne Family Office first reported a position in GILD in Q2 2013 and held it in 7 quarters. The position peaked at $113M in Q3 2018. 1,491 funds tracked by Wall St. Rank hold GILD as of Q1 2019.

Duquesne Family Office reported no remaining Gilead Sciences position as of Q1 2019 after selling out during the quarter.
Duquesne Family Office sold 1,023,345 Gilead Sciences shares in Q1 2019, an estimated $64M.
Duquesne Family Office first reported a position in Gilead Sciences in Q2 2013 and held it in 7 quarters.
Duquesne Family Office's Gilead Sciences position peaked at $113M in Q3 2018.
1,491 funds tracked by Wall St. Rank held Gilead Sciences as of Q1 2019.

Based on Duquesne Family Office's 13F filing for Q1 2019, filed 15 May 2019.